Literature DB >> 20425219

Tonabersat: a cortical spreading depression inhibitor as potential pharmacologic prophylaxis in migraine with aura.

Ivan Garza1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20425219     DOI： 10.1007/s11910-009-0083-9

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  8 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Spreading depression: from serendipity to targeted therapy in migraine prophylaxis.

Authors:  C Ayata
Journal:  Cephalalgia       Date:  2009-10       Impact factor: 6.292

3.  Suppression of cortical spreading depression in migraine prophylaxis.

Authors:  Cenk Ayata; Hongwei Jin; Chiho Kudo; Turgay Dalkara; Michael A Moskowitz
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

Review 4.  Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study.

Authors:  M C Kruit; M A van Buchem; L J Launer; G M Terwindt; M D Ferrari
Journal:  Cephalalgia       Date:  2010-02       Impact factor: 6.292

Review 5.  The epidemiology, burden, and comorbidities of migraine.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurol Clin       Date:  2009-05       Impact factor: 3.806

6.  A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.

Authors:  J F Tvedskov; H K Iversen; J Olesen
Journal:  Cephalalgia       Date:  2004-10       Impact factor: 6.292

7.  Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.

Authors:  P J Goadsby; M D Ferrari; A Csanyi; J Olesen; J G Mills
Journal:  Cephalalgia       Date:  2009-02-13       Impact factor: 6.292

8.  Migraine headache in middle age and late-life brain infarcts.

Authors:  Ann I Scher; Larus S Gudmundsson; Sigurdur Sigurdsson; Anna Ghambaryan; Thor Aspelund; Gudny Eiriksdottir; Mark A van Buchem; Vilmundur Gudnason; Lenore J Launer
Journal:  JAMA       Date:  2009-06-24       Impact factor: 56.272
  8 in total
  1 in total

1.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.